hualurinidases added to supraclavicular brachial plexus block

Effect of hualurinidases added to different concentration of bupivacaine on quality of ultrasound guided supraclavicular brachial plexus block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202002803417431

Enrollment

Registered

2020-02-28

Start date

2020-01-18

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Hyaluronidase group

bupivacaine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 60 adult patients with chronic renal failure which defined as progressive kidney damage with glomerular filtration rate (GFR) <15 mL/min/1.73 m2 for 3 months or more irrespective of cause and progress to point of end stage renal disease (ESRD) which is the point of needing dialysis 2. physical status ASA III classification scheduled for elective arterio- venous shunt creation surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with neurological deficit with upper limb. 2. Bleeding disorders (coagulopathy). 3. Mental dysfunction. 4. History of drug abuse. 5. Chronic analgesic use. 6. History of allergy to local anesthetics.

Design outcomes

Primary

Measure	Time frame
Primary outcome will be duration of sensory block	—

Secondary

Measure	Time frame
secondary outcomes will be complications and success rate.	—

Countries

Egypt

Contacts

Public Contactnada omara

assistant lecturer

Dr.nada.emera@gmail.com0201118342012

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026